Study of the Physiology of Pre-eclampsia and Vascular Intrauterine Growth Restriction With Constitution of a Biological Collection
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 500
- 试验地点
- 2
- 主要终点
- genomic analysis on placenta
研究概览
简要总结
Preeclampsia and intrauterine growth retardation (IUGR) are serious and frequent pathologies, specific to pregnancy. They represent 70 000 new cases a year, or 9% of pregnancies and cause 50,000 premature births per year in France. The consequences in terms of morbidity and perinatal morbidity and the medical and economic costs make it an issue public health. Pre-eclampsia associates maternal hypertension with dysfunction kidney. There is no cure for pre-eclampsia or IUGR vascular during pregnancy. These pathologies invariably evolve towards a maternal and / or fetal aggravation sometimes very fast. Primary prevention and secondary education and screening for these pathologies are still insufficient. A better understanding of the pathophysiology of these placental vascular pathologies is necessary for the development of supported medical, obstetric and pediatric that will improve the state of health maternal and neonatal
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •pregnant women
- •With or without vascular pathology
排除标准
- •refusal to participate
- •multiple pregnancy
- •major fetal malformation diagnosed during pregnancy follow-up
结局指标
主要结局
genomic analysis on placenta
时间窗: day of delivery
by chromatin immunoprecipitation-sequencing (ChIP-seq)
次要结局
- genomic analysis on placenta(day of delivery)
- PLGF blood level(day of delivery)
- sFlt1 blood level(day of delivery)
- genomic analysis on blood(day of delivery)
- VEGF blood level(day of delivery)
- sKDR blood level(day of delivery)
